Insufficient scRNA-seq data for expression of ASAH2 at single-cell level.
Insufficient scRNA-seq data for expression of ASAH2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
liver | 98% | 79.60 | 222 / 226 | 29% | 1.01 | 119 / 406 |
stomach | 96% | 175.33 | 345 / 359 | 15% | 0.43 | 42 / 286 |
esophagus | 88% | 32.42 | 1269 / 1445 | 16% | 0.32 | 29 / 183 |
bladder | 100% | 37.10 | 21 / 21 | 3% | 0.04 | 13 / 504 |
kidney | 96% | 53.38 | 85 / 89 | 2% | 0.03 | 14 / 901 |
breast | 90% | 38.09 | 411 / 459 | 8% | 0.10 | 84 / 1118 |
pancreas | 93% | 47.84 | 304 / 328 | 4% | 0.19 | 7 / 178 |
adrenal gland | 92% | 75.84 | 238 / 258 | 4% | 0.08 | 10 / 230 |
prostate | 93% | 54.56 | 228 / 245 | 3% | 0.04 | 16 / 502 |
intestine | 91% | 71.94 | 880 / 966 | 5% | 0.09 | 25 / 527 |
thymus | 93% | 48.00 | 607 / 653 | 3% | 0.40 | 16 / 605 |
skin | 92% | 48.27 | 1657 / 1809 | 0% | 0.00 | 1 / 472 |
ovary | 91% | 50.76 | 163 / 180 | 1% | 0.02 | 4 / 430 |
brain | 89% | 61.61 | 2340 / 2642 | 3% | 0.03 | 19 / 705 |
lung | 85% | 31.76 | 491 / 578 | 5% | 0.09 | 62 / 1155 |
blood vessel | 87% | 31.13 | 1157 / 1335 | 0% | 0 | 0 / 0 |
uterus | 85% | 37.99 | 145 / 170 | 0% | 0.01 | 2 / 459 |
adipose | 85% | 29.13 | 1028 / 1204 | 0% | 0 | 0 / 0 |
muscle | 85% | 29.49 | 682 / 803 | 0% | 0 | 0 / 0 |
spleen | 81% | 20.54 | 195 / 241 | 0% | 0 | 0 / 0 |
heart | 80% | 31.89 | 693 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 23% | 16.66 | 217 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 3% | 0.03 | 2 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006670 | Biological process | sphingosine metabolic process |
GO_0044241 | Biological process | lipid digestion |
GO_0006672 | Biological process | ceramide metabolic process |
GO_0046514 | Biological process | ceramide catabolic process |
GO_0046513 | Biological process | ceramide biosynthetic process |
GO_0071345 | Biological process | cellular response to cytokine stimulus |
GO_0007346 | Biological process | regulation of mitotic cell cycle |
GO_0046512 | Biological process | sphingosine biosynthetic process |
GO_2001234 | Biological process | negative regulation of apoptotic signaling pathway |
GO_0042759 | Biological process | long-chain fatty acid biosynthetic process |
GO_0006915 | Biological process | apoptotic process |
GO_0005576 | Cellular component | extracellular region |
GO_0005886 | Cellular component | plasma membrane |
GO_0045121 | Cellular component | membrane raft |
GO_0005739 | Cellular component | mitochondrion |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0000139 | Cellular component | Golgi membrane |
GO_0005901 | Cellular component | caveola |
GO_0017040 | Molecular function | N-acylsphingosine amidohydrolase activity |
GO_0102121 | Molecular function | ceramidase activity |
GO_0008270 | Molecular function | zinc ion binding |
GO_0005509 | Molecular function | calcium ion binding |
Gene name | ASAH2 |
Protein name | Neutral ceramidase (EC 3.5.1.23) Neutral ceramidase (N-CDase) (NCDase) (EC 3.5.1.-) (EC 3.5.1.23) (Acylsphingosine deacylase 2) (BCDase) (LCDase) (hCD) (N-acylsphingosine amidohydrolase 2) (Non-lysosomal ceramidase) [Cleaved into: Neutral ceramidase soluble form] N-acylsphingosine amidohydrolase 2 |
Synonyms | HNAC1 |
Description | FUNCTION: Plasma membrane ceramidase that hydrolyzes sphingolipid ceramides into sphingosine and free fatty acids at neutral pH . Ceramides, sphingosine, and its phosphorylated form sphingosine-1-phosphate are bioactive lipids that mediate cellular signaling pathways regulating several biological processes including cell proliferation, apoptosis and differentiation . Also catalyzes the reverse reaction allowing the synthesis of ceramides from fatty acids and sphingosine . Together with sphingomyelinase, participates in the production of sphingosine and sphingosine-1-phosphate from the degradation of sphingomyelin, a sphingolipid enriched in the plasma membrane of cells . Also participates in the hydrolysis of ceramides from the extracellular milieu allowing the production of sphingosine-1-phosphate inside and outside cells (By similarity). This is the case for instance with the digestion of dietary sphingolipids in the intestinal tract (By similarity). . |
Accessions | A0A0C4DFQ8 V9GY52 ENST00000474434.2 ENST00000489640.5 ENST00000682911.1 [Q9NR71-1] Q9NR71 ENST00000395526.9 [Q9NR71-1] ENST00000329428.10 ENST00000443575.5 E9PBM9 V9GYJ5 |